Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease
Clinical trial NCT03992469 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03992469
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2026-02-02
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.